Drug details
HyQvia (immune globulin infusion 10% (human) recombinant human hyaluronidase for subcutaneous administration)
type of Immune Globulins
HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution for Subcutaneous Administration is an immune globulin with a recombinant human hyaluronidase used to treat Primary Immunodeficiency (PI) in adults. This includes, but is not limited to:
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- lightheadedness,
- shortness of breath,
- rapid breathing,
- tiredness,
- yellowing of the skin or eyes (jaundice),
- chest pain,
- dizziness,
- severe headache,
- swelling,
- wheezing,
- weakness,
- vomiting
- flu symptoms,
- dark colored urine,
- mouth sores,
- sudden cough,
- rapid weight gain,
- sudden numbness or weakness (especially on one side of the body),
- slurred speech,
- problems with vision or balance,
- high fever,
- coughing up blood,
- pale or yellowed skin,
- little or no urinating,
- neck stiffness,
- increased sensitivity to light,
- nausea, and
- rapid or fast heart rate,
- pain, swelling, warmth, and redness or discoloration in your arm or leg,
- blue lips, pale or blue colored appearances in your fingers or toes,